CD86 and lymphoma: However, we found that Daudi cells and other non-Hodgkin EBV + lymphoma lines, including Namalwa, express significant levels of PU.1 consistent with previous reports46 and this may explain the higher basal expression of B7-2 compared to PEL lines.